002566.SZ · 益盛药业
China A-shares · RS rating 75 · As of 2026-10-14
| Price | 6.85 CNY |
|---|---|
| 1-day change | -2.1% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 64 / 83 / 56 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 25 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -10.5% |
| Distance from 52-week high | +24.3% |
| Market cap (USD) | $350.4M |